Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.080
+0.260 (14.29%)
At close: Apr 14, 2026, 4:00 PM EDT
2.080
0.00 (0.00%)
Pre-market: Apr 15, 2026, 4:17 AM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $49.32 million as of April 15, 2026. Its market cap has decreased by -66.69% in one year.
Market Cap
49.32M
Enterprise Value
36.16M
1-Year Change
-66.69%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $49.32M, a decrease of -67.58%. That is a compound annual growth rate of -49.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 43.16M | -69.66% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 42.54M |
| Lite Strategy | 42.18M |
| Telomir Pharmaceuticals | 41.94M |
| Rein Therapeutics | 41.78M |
| NextCure | 41.44M |
| Hyperion DeFi | 41.35M |
| Werewolf Therapeutics | 41.26M |
| Sensei Biotherapeutics | 40.06M |